In hypertension, the kidney rules

Current Hypertension Reports

Volumn 9, Issue 2, 2007, Pages 148-153

  Crowley, Steven D ^b   Coffman, Thomas M ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYOSIN HEAVY CHAIN BETA;

ANTIHYPERTENSIVE ACTIVITY; APPARENT MINERALOCORTICOID EXCESS SYNDROME; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DRUG EFFICACY; ENZYME REGULATION; GENE EXPRESSION; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERPLASIA; HYPERTENSION; HYPOTENSION; KIDNEY; KIDNEY TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PRESSOR RESPONSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SHOCK; SODIUM ABSORPTION; SODIUM RETENTION; UPREGULATION; VASOCONSTRICTION; VASOPRESSIN RELEASE;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; HOMEOSTASIS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; VASCULAR RESISTANCE;

EID: 34249055577     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-007-0026-2     Document Type: Review

References (52)

1. Guyton AC: Blood pressure control - special role of the kidneys and body fluids. Science 1991, 252:1813-1816.
2. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001, 104:545-556.
3. Husain A, Graham R: Enzymes and Receptors of the Renin-Angiotensin System: Celebrating a Century of Discovery. Sidney: Harwood Academic; 2000.
4. Brenner BM, Cooper ME, de Zeeuw D, et al.: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345: 861-869.
5. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987, 316:1429-1435.
6. Cohn JN, Tognoni G: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667-1675.
7. Ito M, Oliverio MI, Mannon PJ, et al.: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 1995, 92:3521-3525.
8. Kim HS, Krege JH, Kluckman KD, et al.: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995, 92:2735-2739.
9. Esther CR Jr, Howard TE, Marino EM, et al.: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 1996, 74:953-965.
10. Yanai K, Saito T, Kakinuma Y, et al.: Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem 2000, 275:5-8.
11. Shanmugam S, Sandberg K: Ontogeny of angiotensin II receptors. Cell Biol Int 1996, 20:169-176.
12. Timmermans PB, Wong PC, Chiu AT, et al.: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993, 45:205-251.
13. Tharaux PL, Coffman TM: Transgenic mice as a tool to study the renin-angiotensin system. Contrib Nephrol 2001:72-91.
14. Murphy TJ, Alexander RW, Griendling KK, et al.: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991, 351:233-236.
15. Sasaki K, Yamano Y, Bardhan S, et al.: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991, 351:230-233.
16. Burson JM, Aguilera G, Gross KW, Sigmund CD: Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol 1994, 267:E260-267.
17. Aguilera G: Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol 1992, 90:53-60.
18. Masilamani S, Kim GH, Mitchell C, et al.: Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest 1999, 104:R19-23.
19. Morris MJ, Wilson WL, Starbuck EM, Fitts DA: Forebrain circumventricular organs mediate salt appetite induced by intravenous angiotensin II in rats. Brain Res 2002, 949:42-50.
20. Davisson RL, Oliverio MI, Coffman TM, Sigmund CD: Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 2000, 106:103-106.
21. Ichikawa I, Brenner BM: Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reabsorption and glomerulotubular balance in the rat. J Clin Invest 1980, 65:1192-1201.
22. Navar LG, Carmines PK, Huang WC, Mitchell KD: The tubular effects of angiotensin II. Kidney Int 1987, 20(Suppl):S81-88.
23. Cogan MG: Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990, 15:451-458.
24. Bell PD, Peti-Peterdi J: Angiotensin II stimulates macula densa basolateral sodium/hydrogen exchange via type 1 angiotensin II receptors. J Am Soc Nephrol 1999, 10 Suppl 11:S225-229.
25. Peti-Peterdi J, Warnock DG, Bell PD: Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002, 13:1131-1135.
26. Hall JE: Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol 1986, 250:R960-972.
27. Oliverio MI, Best CF, Smithies O, Coffman TM: Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. Hypertension 2000, 35:550-554.
28. Crowley SD, Gurley SB, Oliverio MI, et al.: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005, 115:1092-1099.
29. Brenner R, Perez GJ, Bonev AD, et al.: Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 2000, 407:870-876.
30. Zhu Y, Bian Z, Lu P, et al.: Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002, 295:505-508.
31. Nishioka T, Callahan MF, Li P, et al.: Increased central angiotensin and osmotic responses in the Ren-2 transgenic rat. Hypertension 1999, 33:385-388.
32. Francois H, Athirakul K, Mao L, et al.: Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 2004, 43:364-369.
33. Vecchione C, Patrucco E, Marino G, et al.: Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. J Exp Med 2005, 201:1217-1228.
34. Crowley SD, Gurley SB, Herrera MJ, et al.: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. PNAS 2006, 103:17985-17990.
35. Guyton AC, Coleman TG, Cowley AV Jr, et al.: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972, 52:584-594.
36. Kawada N, Dennehy K, Solis G, et al.: TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 2004, 287:F753-759.
37. Koren MJ, Devereux RB, Casale PN, et al.: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991, 114:345-352.
38. Levy D, Garrison RJ, Savage DD, et al.: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561-1566.
39. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75:977-984.
40. Schmieder RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996, 275:1507-1513.
41. Mathew J, Sleight P, Lonn E, et al.: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001, 104:1615-1621.
42. Devereux RB, Dahlof B, Gerdts E, et al.: Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004, 110:1456-1462.
43. Paradis P, Dali-Youcef N, Paradis FW, et al.: Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A 2000, 97:931-936.
44. Hein L, Stevens ME, Barsh CS, et al.: Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A 1997, 94:6391-6396.
45. Zhai P, Yamamoto M, Galeotti J, et al.: Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice. J Clin Invest 2005, 115:3045-3056.
46. Lee RT, Bloch KD, Pfeffer JM, et al.: Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest 1988, 81:431-434.
47. Nakagawa O, Ogawa Y, Itoh H, et al.: Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995, 96:1280-1287.
48. D'Angelo DD, Sakata Y, Lorenz JN, et al.: Transgenic Galpha q overexpression induces cardiac contractile failure in mice. PNAS 1997, 94:8121-8126.
49. Harada K, Komuro I, Shiojima I, et al.: Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 1998, 97:1952-1959.
50. van Kats JP, Methot D, Paradis P, et al.: Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem 2001, 276:44012-44017.
51. Griffin KA, Bidani AK: Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade. Clin J Am Soc Nephrol 2006, 1:1054-1065.
52. Svensson P, de Faire U, Sleight P, et al.: Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension 2001, 38:E28-32.